Exhibit 10.1
 
RESTRICTED UNIT AWARD AGREEMENT
 
This Restricted Unit Award Agreement (“Agreement”), dated September  21, 2011,
evidences an award of restricted units made by Ralcorp Holdings, Inc.
(“Company”) to T.G. Granneman (“Executive”), each of which represents the right
to receive on settlement the cash value of one (1) share of Company common
stock, $.01 par value (“Common Stock”), subject to all terms and conditions
herein.
 
Recital
 
The Company has determined that it is in the best interests of the Company and
its shareholders to grant Executive the restricted units, as provided in this
Agreement and subject to all terms and conditions herein, upon forfeiture by
Executive of that certain Restricted Stock Unit Agreement, dated October 9,
2009, and any and all rights thereunder.
 
Agreements
 
NOW THEREFORE, in consideration of the premises, and of the mutual agreements
hereinafter set forth, the Company and Executive agree as follows:
 

 1.   Grant of Restricted Units.  The Company hereby grants to Executive 12,500
restricted units (the “Units”) on September 21, 2011, subject to the terms and
conditions set forth below.  Each such Unit is a bookkeeping entry that
represents the right to receive on a date determined in accordance with this
Agreement a cash payment equal to the Fair Market Value of one share of the
Company’s common stock, par value $0.01 per share (“Common Stock”), subject to
the risk of cancellation and forfeiture as described herein.

 

2.   Restrictions

 

 a.   The Units are subject to restrictions which shall lapse and be removed,
and the Units shall become one hundred percent (100%) vested and nonforfeitable
on December 31, 2013 (“Vesting Date”), provided that Executive remains
continuously employed with the Company through the Vesting Date and further
provided that attainment of the following performance target (“Performance
Target”) is achieved:  The compounded annual growth in the Company’s earnings
per share over the course of fiscal years 2010 and 2011 of no less than
10%.  Notwithstanding the foregoing, the units shall become one hundred percent
(100%) vested and nonforfeitable on the date of:  (i) involuntary termination of
employment by the Company without Cause after the Performance Target is
achieved, (ii) Executive’s retirement at or after age 62 after the Performance
Target is achieved, (iii) death, (iv) Disability, or (v) Change of Control,
provided that Executive remains continuously employed with the Company through
the date any such event occurs and further provided that such event occurs
before December 31, 2013.  For purposes of this Agreement, the term “Fair Market
Value” shall mean the value of one share of Common Stock, determined by
reference to the closing price of the Common Stock as reported by the New York
Stock Exchange or, if the closing price of the Common Stock is not so reported,
then by any means deemed reasonable under the circumstances by the Corporate
Governance and Compensation Committee of the Board of Directors of the Company
or any successor committee as designated by the Board of Directors to the
Company.

          
 
 
 
1

--------------------------------------------------------------------------------

 
              

 b.   In the event that the restrictions do not lapse or are not removed on or
before the Vesting Date, Executive shall forfeit all of the Units, and Executive
shall not be entitled to any payment or other consideration hereunder.

 

 3.   Termination of Employment.  In the event that Executive’s employment
terminates for any reason or no reason, with or without cause, voluntarily or
involuntarily, Executive shall forfeit all Units which are not, as of the time
of such termination, vested, and Executive shall not be entitled to any payment
or other consideration with respect thereto; provided, however, that on the
termination of Executive’s employment prior to December 31, 2013 due to
involuntary termination by the Company without Cause or due to retirement at or
after age 62, in either event, after the Performance Target is achieved (and
only if such Performance Target is so achieved in either such event) or death,
the Units hereunder shall vest immediately on the date of such death,
involuntary termination without Cause, or retirement at or after age 62.

 

 4.   Settlement of the Restricted Units.

 

 a.   Subject to the terms and conditions of this Agreement, the Company shall
deliver to Executive (or, in the event of death, the person designated under the
Plan in such event) a cash payment for each vested Unit equal to the Fair Market
Value of one share of Common Stock on the first business day which is more than
six months following the date of Executive’s termination of employment.  For
this purpose, a termination of employment will be determined in a manner
consistent with Section 409A of the Code, and the regulations and guidance
thereunder.

         

 b.   As of each dividend payment date for each cash dividend on the Common
Stock, the Company shall award Executive additional restricted units, which
shall be subject to the same terms and conditions as the Units granted pursuant
to this Agreement.  The number of additional restricted units to be granted
shall equal (i) the product of (x) the per-share cash dividend payable with
respect to each share of Common Stock on that date, multiplied by (y) the total
number of Units which have not been paid or forfeited as of the record date for
such dividend, divided by (ii) the Fair Market Value of one share of Common
Stock on the payment date of such dividend.  The number of additional Units to
be granted if the dividend is paid in the form of Common Stock shall be
determined in accordance with the manner in which adjustments are determined
with respect to stock-based awards under the Amended and Restated Ralcorp
Holdings, Inc. 2007 Incentive Stock Plan, as amended from time to time
(“Plan”).  In addition, in the event that any event occurs that would require a
mandatory adjustment to awards in accordance with the Plan, the Units granted
under this Agreement shall be adjusted in accordance with the manner in which
adjustments are determined with respect to stock-based awards under the Plan.

      

 5.   Withholding Taxes.  Executive shall pay to the Company, or make provision
satisfactory to the Company for payment of, any federal, state, local or foreign
taxes required by law to be withheld in connection with the Award, no later than
the date on which such withholding is required under applicable law.

 

 6.   No Shareholder Rights.  No rights of a shareholder shall exist with
respect to the Units.  Without limiting the foregoing, Executive shall not be
entitled to receive, currently or on a deferred basis, any payments equivalent
to cash, stock or other property paid by the Company as dividends on the Common
Stock, except to the extent set forth in Section 4b.

 

 7.   Restrictive Covenants.

 

 a.   Non-Competition.

 
 
 
 
 
2

--------------------------------------------------------------------------------

 
               

 i.   During the term of Executive’s employment with the Company (or one of its
subsidiaries or affiliates) and for one (1) year thereafter, except in the
course of Executive performing his/her job responsibilities with the Company,
Executive will not directly or indirectly, in a competitive capacity, engage or
invest in, own, manage, operate, finance, control or participate in the
ownership, management, operation, financing or control of, be employed by or
under contract with (including as a director, advisor, or consultant), lend
Executive’s name or any similar name to, lend Executive’s credit to or render
services or advice to, or plan or prepare to do any of the foregoing with any
business organization or entity whose products or activities compete or intend
to compete with the Company in the United States or Canada on food products
produced by the Company (including those of its subsidiaries and operating
divisions) (“Competing Company”) at the time of termination of employment;
provided however, Executive may purchase or otherwise acquire up to (but not
more than) five percent (5%) of any class of securities of any entity (but
without otherwise participating in the activities of such entity) if such
securities are listed on any national or regional securities exchange or have
been registered under §12(g) of the Securities Exchange Act of 1934, as
amended.  For purposes of this Agreement, a business entity or organization
shall be a Competing Company only if more than ten percent (10%) of its
aggregate gross revenues and more than ten percent (10%) of its aggregate net
income are derived from products or activities which compete or intend to
compete with the Company’s food products in the United States and Canada.

     

 ii.   In the event Executive violates this Section 7(a), Executive shall
deliver to the Company, within five (5) days of receipt by Executive of a
written demand therefore, a cash payment equal to the amount paid to Executive
under this Agreement with respect to the Units.  In the event Executive fails to
pay this amount within five (5) days of receipt of a written demand, the Company
shall have the right to seek and obtain any equitable and injunctive relief
(without the requirement to post a bond) that a court may determine is
appropriate.  To the extent that the Company is successful in enforcing this
provision, Executive shall be responsible for paying the Company’s reasonable
attorney’s fees and costs.

 

 b.   Non-Solicitation/Non-Hire.

             

 i.   Whether for Executive’s own account or the account of any other person or
entity, Executive will not (i) at any time during the Executive’s employment
with the Company and for one (1) year after Executive’s termination of
employment, directly or indirectly, solicit as an employee, independent
contractor or otherwise, any person who was a salaried and bonus eligible
employee of the Company at any time during the term of Executive’s employment
with the Company or in any manner induce or attempt to induce any employee of
the Company to terminate his or her employment with the Company or any
affiliate; or (ii) at any time during the Executive’s employment with the
Company and for one (1) year after Executive’s termination of employment,
interfere with the Company’s relationship with any person or entity who was a
customer or supplier of the Company at the time of Executive’s termination of
employment.

                        

 ii.   In the event Executive violates any provision of this Section 7(b), the
Company shall have the right to take all necessary legal action to enforce this
provision.  In addition to any remedies available at law, the Company shall have
the right to seek and obtain any equitable and injunctive relief (without the
requirement to post a bond) that a court may determine is appropriate.  To the
extent that the Company is successful in enforcing this provision, Executive
shall be responsible for paying the Company’s reasonable attorneys’ fees and
costs.

                 
 
 
3

--------------------------------------------------------------------------------

 
                  

 iii.   If Executive breaches any covenant concerning non hire or non
solicitation contained herein or to which Executive is or may become a party in
the future, then, in addition to and without in any way limiting the foregoing
or any other remedies:

 

 A.   any unvested Units and any vested Units that have not settled as provided
herein shall be forfeited automatically on the date Executive commits such
breach;

                       

 B.   in the event of such a breach, Executive shall pay the Company, within
five (5) days of receipt by Executive of a written demand therefor, an amount in
cash equal to the amount determined; and

                        

 C.   Executive shall pay any damages in excess of the amounts paid to the
Company under the foregoing.

                        

 c.   The parties acknowledge and agree that the time and other limitations
contained in this Section are reasonable and necessary for the proper protection
of the Company.  However, if any arbitrator or court of competent jurisdiction
finds that the time period of the foregoing covenants is too lengthy or the
geographic coverage and scope of the covenants is too broad, the restrictive
time period shall be deemed to comprise the largest scope permissible by law
under the circumstances.  Executive further acknowledges that, in the event of
the termination of his employment with the Company, Executive’s skills and
experience will permit him to find employment in many markets, and the
limitations contained herein will not prevent him from earning a
livelihood.  The period of time applicable to any covenant in this Section shall
be extended by the duration of any actual or threatened violation by Executive
of such covenant.

               

 8.   Additional Definitions.

 

a.   For purposes of this Agreement, the following terms have the meanings set
forth below:

            

 i.   “Cause” shall mean Executive’s willful engaging in gross misconduct;
provided, however, that a termination for cause shall not include termination
attributable to (i) poor work performance, bad judgment or negligence on the
part of Executive, (ii) an act or omission believed by Executive in good faith
to have been in or not opposed to the best interest of the Company and
reasonably believed by Executive to be lawful, or (iii) the good faith conduct
of Executive in connection with a Change of Control (including opposition to or
support of such Change of Control).

 

 ii.   “Change of Control” shall mean when (i) a person, as defined under the
securities laws of the United States, acquires all or substantially all of the
assets of the Company or acquires beneficial ownership of more than 50% of the
outstanding voting securities of the Company; or (ii) the directors of the
Company, immediately before a business combination between the Company and
another entity, or a proxy contest for the election of directors, shall as a
result of such business combination or proxy contest, cease to constitute a
majority of the Board of Directors of the Company or any successor to the
Company.  Notwithstanding the foregoing, a Change of Control shall not include a
transaction in which the Company is the continuing or surviving corporation and
which does not result in the outstanding shares of Common Stock being converted
into or exchanged for different securities, cash, or other property, or any
combination thereof.

                
                   
 
 
4

--------------------------------------------------------------------------------

 
                 

 iii.   “Disability” means Executive is unable to engage in any substantial
gainful activity by reason of any medically determinable physical or mental
impairment that can be expected to result in death or can be expected to last
for a continuous period of not less than 12 months; or, Executive is, by reason
of any medically determinable physical or mental impairment that can be expected
to result in death or can be expected to last for continuous period of not less
than 12 months, receiving income replacement benefits for a period of not less
than three months under an accident and health plan covering employees of
Ralcorp.

 

 9.   Entire Agreement.  The Award is subject in all respects to the terms and
conditions of this Agreement.  No other communications or representations,
written or oral, made prior or subsequent to this Agreement shall be deemed to
amend or modify the terms of this Agreement except by an agreement in writing
executed by the parties subsequent to the date of this Agreement expressly
consenting to such amendment or modification.  Executive hereby waives any
rights, and releases Company from any claim, based on any such prior
communications or representations, if any.  Notwithstanding anything herein to
the contrary, Executive hereby forfeits and waives any rights, and releases
Company from any claim, relating to that certain Restricted Stock Unit
Agreement, dated October 9, 2009 (“Prior Unit Agreement”) between the Company
and Executive, and the parties agree that this Agreement shall expressly amend
the Prior Unit Agreement to terminate such agreement and make such agreement
void and of no further force or effect.

 

 10.   No Employment Rights.  This Agreement is not intended to create and
should not be construed as creating a contract guaranteeing employment of any
duration with the Company or its subsidiaries or affiliates.  Employment with
the Company and its subsidiaries and affiliates is at will and can be terminated
by Executive or the Company at any time, for any reason, with or without notice.

         

 11.   Binding Effect.  This Agreement shall inure to the benefit of and be
binding upon the Company and its successors.  This Agreement shall be binding
upon Executive and Executive’s heirs, executors, administrators, and
assigns.  Executive shall have no right to transfer or assign the right to
receive the Award under this Agreement.

         

 12.   Not Funded/Claims.

   

a.   Any payments or amounts due under this Agreement are unfunded obligations
of the Company.  The Committee shall have the right to determine in its good
faith judgment whether the Performance Target has been achieved in the event of
unusual or non reoccurring items that impact the Company’s earnings per share.

            

b.   Executive or other person who feels he is entitled to a benefit or right
provided under this Agreement, or his authorized representative, (hereinafter
referred to as “Claimant”) may make a claim, i.e., a request for benefits under
this Agreement, pursuant to the Committee’s procedures.

             

c.   The Company shall, within 90 days after its receipt of such claim, make its
determination.  However, if special circumstances require an extension of time
for processing the claim, the Company shall furnish the Claimant, within 90 days
after its receipt of such claim, written notification of the extension
explaining the circumstances requiring such extension and the date that it is
anticipated that such written statement will be furnished, and shall provide
such Claimant with its determination not later than 180 days after receipt of
the Claimant’s claim.

              
 
 
5

--------------------------------------------------------------------------------

 
 
In the event the claim is denied, the Company shall provide such Claimant a
written statement of the Adverse Benefit Determination, as defined below.  The
notice of Adverse Benefit Determination shall be delivered or mailed to the
Claimant by certified or registered mail to his last known address, which
statement shall contain the following:
 

 i.   the specific reason or reasons for Adverse Benefit Determination;

 

 ii.   a reference to the specific provisions of the Agreement upon which the
Adverse Benefit Determination is based;

                   

 iii.   a description of any additional material or information that is
necessary for the Claimant to perfect the claim;

                                     

 iv.   an explanation of why that material or information is necessary; and

               

 v.   an explanation of the review procedure provided below, including
applicable time limits and a notice of a Claimant’s rights to bring a legal
action under ERISA after an Adverse Benefit Determination on appeal.

 
                  

d.   Within 60 days after receipt of a notice of an Adverse Benefit
Determination as provided above, if the Claimant disagrees with the Adverse
Benefit Determination, the Claimant, or his authorized representative, may
request, in writing, that the Committee review his claim and may request to
appear before the Committee for such review.  If the Claimant does not request a
review of the Adverse Benefit Determination within such 60 day period, he shall
be barred and estopped from appealing the Company’s Adverse Benefit
Determination.  Any appeal shall be filed with the Committee at the address
prescribed by the Committee, and it shall be considered filed on the date it is
received by the addressee.  In deciding any appeal, the Committee shall act in
its capacity as a named fiduciary.

          
The Claimant shall have the rights to:
 

 i.   submit written comments, documents, records and other information relating
to the claim for benefits;

               

 ii.   request, free of charge, reasonable access to, and copies of all
documents, records and other information relevant to his claim for benefits.

                  

e.   Within 60 days after receipt by the Committee of a written application for
review of a Claimant’s claim, the Committee shall notify the Claimant of its
decision by delivery or by certified or registered mail to his last known
address; provided, however, in the event that special circumstances require an
extension of time for processing such application, the Committee shall so notify
the Claimant of its decision not later than 120 days after receipt of such
application.

               
In the event the Committee’s decision on appeal is adverse to the Claimant, the
Committee shall issue a written notice of an Adverse Benefit Determination on
Appeal that will contain all of the following information, in a manner
calculated to be understood by the Claimant:
 

 i.   the specific reason(s) for the Adverse Benefit Determination on Appeal;

                   

 ii.   reference to specific Agreement provisions on which the benefit
determination is based;

 
             
 
 
6

--------------------------------------------------------------------------------

 
                  

 iii.   a statement that the Claimant is entitled to receive, upon request and
free of charge, reasonable access to and copies of all documents, records and
other information relevant to the Claimant’s claim for benefits; and a statement
of the Claimant’s right to bring an action under ERISA Section 502(a).

 

f.   Notwithstanding anything herein, if a Claimant is denied a benefit because
he is determined not to be disabled and he makes a claim pursuant to such
denial, the provisions of this subsection shall apply.  Upon receipt of a claim,
the reply period shall be forty-five (45) days.  If, prior to the end of such
45-day period, the claims reviewer determines that, due to matters beyond its
control, a decision cannot be rendered, the period for making the determination
may be extended for up to thirty (30) days, and the claims reviewer shall notify
the Claimant, prior to the expiration of such 45-day period, of the
circumstances requiring an extension and the date by which the reviewer expects
to render a decision.  If, prior to the end of the first 30-day extension
period, the claims reviewer determines that, due to matters beyond its control,
a decision cannot be rendered within that extension period, the period for
making the determination may be extended for up to an additional thirty (30)
days, and the claims reviewer shall notify the Claimant, prior to the expiration
of the first 30-day extension period, of the circumstances requiring the
extension and the date by which it expects to render a decision.  In the case of
any extension described in this paragraph, the notice of extension shall
specifically explain the standards on which entitlement to a benefit is based,
the unresolved issues that prevent a decision on the claim and the additional
information needed to resolve those issues, and the Claimant shall be afforded
forty-five (45) days within which to provide the specified information.  If
information is requested, the period for making the benefit determination shall
be tolled from the date on which notification of an extension is sent to the
Claimant until the date on which the Claimant responds to the request for
information.

             
Within one hundred eighty (180) days after receiving the written notice of an
adverse disposition of the claim, the Claimant may request in writing, and shall
be entitled to, a review of the benefit determination.  In deciding an appeal of
any adverse benefit determination that is based in whole or in part on a medical
judgment, the reviewer shall consult with a health care professional who has
appropriate training and experience in the field of medicine involved in the
medical judgment.  Such health care professional shall be an individual who is
neither an individual who was consulted in connection with the adverse benefit
determination that is the subject of the appeal nor the subordinate of any such
individual.  The medical or vocational experts whose advice was obtained on
behalf of the reviewer in connection with the Claimant’s adverse benefit
determination will be identified to the Claimant.  If the Claimant does not
request a review within one hundred eighty (180) days after receiving written
notice of the original’s disposition of the claim, the Claimant shall be deemed
to have accepted the original written disposition.
 
A decision on review shall be rendered in writing within a reasonable period of
time, but ordinarily not later than forty-five (45) days after receipt of the
Claimant’s request for review, unless the reviewer determines that special
circumstances require an extension of time for processing the claim.  If an
extension of time for processing is required, written notice of the extension
shall be furnished to the Claimant prior to the termination of the initial
forty-five (45) period.  In no event shall such extension exceed a period of
forty-five (45) days from the end of the initial period.  The extension notice
shall indicate the special circumstances requiring an extension of time and the
date by which the reviewer expects to render the determination on review.  In
the event the extension is due to a Claimant’s failure to submit information
necessary to decide the claim, the Claimant shall be afforded forty-five (45)
days within which to provide the specified information, and the period for
making the benefit determination on review shall be tolled from the date on
which notification of the extension is sent to the Claimant until the date on
which the Claimant responds to the request for additional information.
 
 
 
7

--------------------------------------------------------------------------------

 
          

g.   As used herein, the term “Adverse Benefit Determination” shall mean a
determination that results in any of the following: the denial, reduction, or
termination of, or a failure to provide or make payment (in whole or in part)
for, a benefit, including any such denial, reduction, termination, or failure to
provide or make payment that is based on a determination of the Claimant’s
eligibility to participate in the Agreement.

     

h.   A Claimant may bring a legal action with respect to a claim only if (i) all
procedures described above have been exhausted, and (ii) the action is commenced
within ninety (90) days after a decision on review is furnished.

               

 13.   Applicable Law.  To the extent that Federal laws do not otherwise
control, this Agreement and all determinations made or actions taken pursuant
hereto shall be governed by the laws of the state of Missouri, without regard to
the conflict of laws rules thereof.

 
      
 

 
IN WITNESS WHEREOF, the parties have executed this Agreement, this 21st day of
September, 2011.
 
RALCORP HOLDINGS, INC.
EXECUTIVE
 
By:    /s/ D. P. Skarie
         D.P. Skarie, Co-CEO and President
 /s/ T. G. Granneman
 T.G. Granneman

 
 
 
 
 

 
8

--------------------------------------------------------------------------------